Difference between revisions of "Wu K, et al. Mol. Med. Rep. (2016) cited as Ref 158 in DOI: 10.1038/s41392-020-0110-5 (Q9421)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Mol. Med. Rep., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Mol. Med. Rep. | ||
| Property / Published In Name String: Mol. Med. Rep. / rank | |||
| + | Normal rank | ||
Revision as of 20:31, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wu K, et al. Mol. Med. Rep. (2016) cited as Ref 158 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wu K
0 references
Ma L
0 references
Zhu J
0 references
2016
0 references
Mol. Med. Rep.
0 references
